Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid IV vs Topical in Intertrochanteric Fractures
NCT04696224Unknown
- Sponsor
- Universidade do Vale do Sapucaí
- Start
- Dec 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tranexamic acid in hemorrhage (3 arms), sponsored by Universidade do Vale do Sapucaí. Primary endpoint: Bleeding loss in operative intertrochanteric fractures at 2 years. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT04696224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04696224.